Exonate
PrivateLast Round
Series A
Jan 3, 2019
Total Funding Raised
$11.79M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Exonate is a biopharmaceutical company developing novel, non-invasive, small-molecule therapeutics for patients with retinal vascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exonate Comparables
Compare Exonate with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanOpttica | 88% | |
| D-Sight | 82% | |
| Retinset, S.L. | 82% |
Exonate Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 3, 2019 | ||||
| Grant | Feb 6, 2017 | ||||
| Angel | Nov 30, 2016 | ||||
| Angel | Oct 5, 2015 | ||||
| Seed | Apr 3, 2014 |
Exonate Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACF Investors | Angel, Series A |
| IP Group | Seed |
| o2h ventures | Angel, Series A |
| University of Bristol Enterprise Fund | Angel, Series A |
| Uniseed | Angel, Series A |
| Parkwalk Advisors | Angel, Series A |
| Wren Capital | Angel, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 58% MoM.
- Feb 6, 2017
Secured $6.1M from Wellcome Trust.
Recent news
Latest coverage and updates
- hiresJun 30, 2026
Exonate was planning to hire Olav Hellebø as Chief Executive Officer on Jun 30th '26.
- hiresJun 30, 2026
Exonate hired Olav Hellebø as Chief Executive Officer on Jun 30th '26.
- hiresJun 30, 2026
Exonate hired Olav as Chief Executive Officer on Jun 30th '26.
Exonate Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Exonate's valuation, stock price, and market status.
Is Exonate a public or private company?
Exonate is a private company.
What is the current stock price of Exonate?
Exonate is a private company with no public stock price. No recent secondary market data is available.
How much is Exonate worth (valuation)?
Valuation information for Exonate is not publicly available.
Can I buy Exonate stock?
Exonate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Exonate's last funding round?
Exonate's most recent funding round was VC Round on January 3, 2019.
Who are the main investors in Exonate?
Key investors in Exonate include Wellcome Trust.
Will Exonate IPO soon?
No public IPO plans have been announced for Exonate.
How can I track Exonate secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Exonate's secondary market activity and sign up for updates.